Introduction
Taxanes represent a family of well known anticancer drugs currently used for treatment of patients with several types of cancer, including breast, ovarian, head and neck, lung, and prostate cancer [1, 2] . Paclitaxel, originally isolated from the bark of the Pacific Yew (Taxus brevifolia), has been shown to possess anticancer activity in vitro in 1971 by Wall and coworkers [3] . In 1992, the Food and Drug Administration (FDA) of the U.S. approved paclitaxel (Taxol ®) to be used in clinical practice for the treatment of breast cancer [4] . Later, paclitaxel was followed by the semisynthetic taxane, docetaxel, and other taxane analogs.
Our understanding of taxane action on the molecular level comes predominantly from studies employing paclitaxel [5] . Paclitaxel reversibly binds to the β-tubulin subunits of microtubules. β-Tubulin together with α-tubulin forms heterodimers, basic units of microtubules [6] . Microtubules, one of the major components of cytoskeleton, are involved in a wide range of cellular functions including cell motility, intracellular trafficking, maintenance of cell shape, and assembly of the mitotic spindle [6, 7] . Binding of paclitaxel to β-tubulin affects inherent dynamic instability of microtubules by accelerating the polymerization of tubulin and inhibiting microtubule depolymerization [8] , making microtubules unusually stable and resistant to depolymerization [9] . Thus, the interaction of paclitaxel with microtubules results in the formation of microtubule bundles in interphase cells and in the formation of asters instead of regular mitotic spindles during mitosis. In this way, taxanes are supposed to block progression through the M phase of the cell cycle [10, 11] and cause cell death. However, the causal relationship of the mitotic arrest induced by taxanes to the induction of cell death is unclear [12] [13] [14] .
It is generally believed that anticancer agents, including taxanes, induce apoptosis through the intrinsic mitochondrial pathway via the release of proapoptotic proteins such as cytochrome c from the mitochondria into the cytosol [15, 16] . It seems that paclitaxel-induced cell death pathways differ according to the origin of cancer cell [17, 18] . After paclitaxel treatment, involvement of mitochondrial pathway of apoptosis with the activation of caspase-9 and caspase-3 has been reported in several breast cancer lines [13, [19] [20] [21] [22] as well as in cancer cells of another origin [17] . On the other hand, paclitaxel has been described to induce cell death independently of activation of caspase-9 and caspase-3 in breast cancer cells [23] . Studies of paclitaxel-induced apoptosis in cancer cells of non-breast origin have shown involvement of other pathways such as death-receptor independent activation of caspase-8 [24] or death-receptor independent activation of caspase-10 [25] .
In clinical practice, paclitaxel and docetaxel are taxanes routinely used. They are known as classical taxanes. Paclitaxel used as a single agent is associated with 30% to 50% response rates for advanced cancers of the breast and ovary, and 20% to 40% response rates for advanced cancers of the lung, head and neck, esophagus, and prostate [5, 26, 27] . Unfortunately, cellular resistance, either primary or secondary, represents a serious limitation to the clinical use of classical taxanes. Therefore, there is an intensive need to elucidate the molecular mechanisms of taxane resistance and to develop new generation of taxanes that would be effective against tumors resistant to the treatment with classical taxanes.
Examples of such taxanes are SB-T-1216 [28] , and fluorinated taxanes SB-T-12851, SB-T-12852, SB-T-12853, SB-T-12854 synthesized by Ojima et al. at Stony Brook [29] . These taxanes are anticipated to be more effective than classical taxanes, especially against paclitaxel-resistant cancer cells. Indeed, SB-T-1216 has been already shown to be more effective against the drug-resistant breast cancer cells in comparison with paclitaxel [30] .
In the present in vitro study, we focused on fluorinated taxanes SB-T-12851, SB-T-12852, SB-T-12853 and SB-T-12854. The main aim of the study was to compare their effect on human cancer cells with that of non-fluorinated classical taxane paclitaxel and non-fluorinated novel taxane SB-T-1216. Employing two cancer cell lines, which differ significantly in their sensitivity to paclitaxel (paclitaxelsensitive MDA-MB-435 cells and highly paclitaxel-resistant NCI/ADR-RES cells), we found that cell death-inducing effect of fluorinated taxanes is comparable with that of previously studied non-fluorinated taxane SB-T-1216 [31] . However, these fluorinated taxanes are significantly more effective than classical taxane paclitaxel, especially against paclitaxel-resistant cells. Cell death induced by all taxanes examined in MDA-MB-435 and NCI/ADR-RES cells was accompanied by the activation of caspase-3, caspase-9, caspase-2 and caspase-8, but was not associated with increased level of reactive oxygen species (ROS), mitochondrial membrane potential collapse and cytochrome c release from mitochondria.
Materials and methods

Materials
Paclitaxel was obtained from Sigma-Aldrich (St. Louis, MO, USA). Novel taxane SB-T-1216 [28] and new fluorinated taxanes [29] SB-T-12851, SB-T-12852, SB-T-12853, SB-T-12854 ( Fig. 1) were synthesized by Prof. I. Ojima (Stony Brook, NY, USA). All taxanes were dissolved in DMSO (tissue culture quality) to obtain 10 mM stock solutions.
Cells and culture conditions
The human breast carcinoma cell lines MDA-MB-435 and NCI/ADR-RES were obtained from National Cancer Institute at Frederick (MD, USA). The cells were maintained in a culture medium at 37°C in a humidified atmosphere of 5% CO 2 in air. The culture medium represents a basic medium supplemented with 10% heatinactivated fetal bovine serum (Biochrom AG, Berlin, Germany). The basic medium was RPMI 1640 medium (Sigma-Aldrich, St. Louis, MO, USA) containing extra Lglutamine (300 µg/ml), sodium pyruvate (110 µg/ml), HEPES (15 mM), penicillin (100 U/ml) and streptomycin (100 µg/ml), as described previously [32] .
Assessment of cell growth and survival
Cells were harvested and seeded at 20×10 3 cells/100 μl of the culture medium into the wells of a 96-well plastic plate. After 24-h preincubation period allowing cells to attach, the culture medium was replaced by the culture medium without a taxane (control) or with tested taxane at desired concentrations. Cell growth and survival were evaluated after 96 h of incubation. The number of living cells was determined by hemocytometer counting after staining with trypan blue [33] .
Cell cycle analysis
Cells (approximately 500×10 3 cells per sample) were seeded. After 24-h preincubation period allowing cells to attach, the culture medium was replaced by the culture medium without a taxane (control) or with tested taxane at the death-inducing concentration. After 12-h and 24-h incubation the cells were harvested by low-speed centrifugation and fixed in cold 70% ethanol overnight at 4°C. Fixed cells were washed with PBS, stained with propidium iodide solution (40 μg/ml propidium iodide and 100 μg/ml RNase in PBS) for 45 min and the fluorescence was measured on a FACS Calibur cytometer (Becton Dickinson, San Jose, CA, USA).
Measurement of caspase-3, caspase-9, caspase-2 and caspase-8 activities Commercial colorimetric Caspase-3 Assay Kit, Caspase-8 Assay Kit and Caspase-9 Assay Kit (Sigma-Aldrich, St.
Louis, MO, USA) as well as solutions from a Caspase-3 Assay Kit (Sigma-Aldrich, St. Louis, MO, USA) combined with the chromogenic caspase-2 substrate and caspase-2 inhibitor (Alexis Biochemicals, Lausen, Switzerland) were used for the assessment of caspase-2, caspase-3, caspase-8 and caspase-9 activities. Cells were seeded at 200×10 3 cells/ml of culture medium (approximately 20×10 6 cells per sample). Taxanes were applied after 24-h preincubation as described above (see "Cell cycle analysis"). After 24-h incubation, cells were harvested by low-speed centrifugation, washed twice with PBS and lysed. The total protein concentration was determined by the BCA™Protein Assay Kit (Pierce, Rockford, IL, USA). Assays were performed in 96-well plates according to the manufacturer's instructions and 100 μg of total protein per sample was analyzed. The sample absorbance was measured at 405 nm using a Sunrise ELISA Reader (Tecan, Maennedorf, Switzerland).
Flow cytometric analysis of the mitochondrial membrane potential (Δψ m )
Cells (approximately 500×10 3 cells per sample) were seeded and taxanes were applied after 24-h preincubation as described above (see "Cell cycle analysis"). After 24-h incubation, the cells were harvested by low-speed centrifugation and resuspended in PBS. The Δψ m was measured as described previously [34] . Cells were kept on ice and 20 nM 3,3'-dihexyloxacarbocyanine iodide [DiOC 6 (3)] from Molecular Probes (Eugene, OR, USA) was added. After 20 min of incubation at 37°C cells were again kept on ice. As a negative control, aliquots of cells were incubated in the presence of 100 μM carbonyl cyanide m-chlorophenylhydrazone (CCCP), a protonophore causing a complete disruption of the Δψ m . The fluorescence was measured using a FACS Calibur cytometer (Becton Dickinson, San Jose, CA, USA).
Flow cytometric analysis of reactive oxygen species (ROS) level
The ROS level was measured by dihydroethidine probe according to the protocol described by Castedo et al. [35] with minor modification. Briefly, cells (approximately 500×10 3 cells per sample) were seeded and taxanes were applied after 24-h preincubation as described above (see "Cell cycle analysis"). After 24-h incubation, the cells were harvested by low-speed centrifugation and resuspended in the culture medium. Cells were kept on ice and 5 μM dihydroethidium (Sigma, St. Louis, MO, USA) was added. After 30 min of incubation at 37°C, cells were again kept on ice. The fluorescence was measured using a FACS Calibur cytometer (Becton Dickinson, San Jose, CA, USA).
Flow cytometric analysis of cytochrome c release
Commercial InnoCyte™ Flow Cytometric Cytochrome c Release Kit (Merck, Darmstadt, Germany) was used for the assessment of cytochrome c release from mitochondria. Cells (approximately 3×10 6 cells per sample) were seeded and taxanes were applied after 24-h preincubation as described above (see "Cell cycle analysis"). After 24-h incubation, the cells were harvested by low-speed centrifugation and resuspended in PBS. The cells were permeabilized with Permeabilization Buffer, then fixed with 8% paraformaldehyde in PBS and repeatedly washed. Blocking Buffer was added and the cells were incubated. After the addition of the primary antibody against cytochrome c, the cells were again incubated and washed. The cells were subsequently incubated with the secondary antiIgG FITC antibody. After washing the cells were resuspended and the fluorescence was measured using a FACS Calibur cytometer (Becton Dickinson, San Jose, CA, USA).
Cell fractionation and western blot analysis of cytochrome c level
Cells (approximately 20×10 6 cells per sample) were seeded and taxanes were applied after 24-h preincubation as described above (see "Cell cycle analysis"). After 24-h incubation, the cells were harvested by low-speed centrifugation and resuspended in PBS. Cell fractionation was performed as described previously [13] .
Western blot analysis of the levels of cytochrome c was carried out with some modifications as described in detail previously [13] . Proteins separated by SDS-PAGE were blotted onto 0.2 µm nitrocellulose membrane for 2 h at 0.25 A using MiniProtean II blotting apparatus (Bio-Rad, Hercules, CA). The membrane was blocked with 5% nonfat milk in TBS for 15 min. Tween-20 (0.1%) in TBS was used for washing. The washed membrane was incubated with the primary rabbit polyclonal antibody #4272 against human cytochrome c (Cell Signaling, Danvers, MA, USA). After the incubation (overnight, 4°C), the washed membrane was incubated for 1 h with the corresponding horseradish peroxidase-conjugated secondary antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA). The horseradish peroxidase-conjugated secondary antibody was detected by enhanced chemiluminiscence using the Supersignal reagent from Pierce (Rockford, IL, USA) and LAS 1000 CCD device (Fuji). As a control of proper fractionation, the primary rabbit polyclonal antibody #4844 (Cell Signaling, Danvers, MA, USA) against the integral mitochondrial protein cytochrome c oxidase IV (COX IV) was used.
Results
Effect of taxanes on growth and survival
The effects of SB-T-12851, SB-T-12852, SB-T-12853 and SB-T-12854 on the growth and survival of drug-sensitive MDA-MB-435 cells [13] were examined at a wide range of concentrations (0.1-300 nM). The effects of all four fluorinated taxanes examined were similar. These fluorinated taxanes induced the death of MDA-MB-435 cells within 96 h of incubation at a concentration of 10 nM and/or higher concentrations. The C 50 values (concentration of taxane resulting in 50% of living cells in comparison with the control after 96 h of incubation) of SB-T-12851, SB-T-12852, SB-T-12853 and SB-T-12854 were 3 nM, 4 nM, 3 nM and 5 nM, respectively (Fig. 2) .
In the case of drug-resistant NCI/ADR-RES cells [13] , the effects of fluorinated taxanes were also examined at a wide range of concentrations (0.3-1,000 nM). Again, the effects of all four fluorinated taxanes examined were more or less similar. These taxanes induced death of NCI/ADR-RES cells within 96 h of incubation at a concentration of 30 nM and/or higher concentrations. The C 50 values of SB-T-12851, SB-T-12852, SB-T-12853 and SB-T-12854 were 20 nM, 20 nM, 10 nM and 10 nM, respectively (Fig. 2) . These data show that about 3-6-fold higher concentrations of fluorinated taxanes are required to induce the death of drug-resistant NCI/ADR-RES cells than that of drugsensitive MDA-MB-435 cells.
Thus, the effects of tested fluorinated taxanes resemble that of the previously studied novel non-fluorinated taxane SB-T-1216. About 3-fold higher concentration of SB-T-1216 was also required to induce the death of NCI/ADR-RES cells than that of MDA-MB-435 cells [31] . On the other hand, an approximately 300-fold higher concentration of classical taxane paclitaxel was required to induce the death of drug-resistant NCI/ADR-RES cells than that of drug-sensitive MDA-MB-435 cells [13] .
On the basis of obtained data, we selected fluorinated taxanes SB-T-12853 and SB-T-12854 for further studies. We also selected 30 nM and 300 nM as the cell deathinducing concentrations, i.e. the lowest concentrations with full death-inducing effect, of tested fluorinated taxanes for MDA-MB-435 cells and NCI/ADR-RES cells, respectively. These concentrations were used in further experiments, comparing the effect of fluorinated taxanes and that of previously studied non-fluorinated novel taxane SB-T-1216 [31] as well the effect of paclitaxel [13] . Under the same experimental conditions, 30 nM and 300 nM were also used as the death-inducing concentrations of SB-T-1216 for MDA-MB-435 and NCI/ADR-RES cells, respectively. In the case of paclitaxel, 30 nM concentration for MDA-MB-435 cells and 3,000 nM concentration for NCI/ADR-RES cells were used as reported previously [13] .
Effect of taxanes on the cell cycle
Flow cytometric analysis, after propidium iodide staining, showed that the application of selected fluorinated taxanes SB-T-12853 and SB-T-12854 at the cell death-inducing concentration (30 nM) led to a significant accumulation of MDA-MB-435 cells in the G 2 /M phase of the cell cycle after 12 h of incubation. After 24 h of incubation, nearly total accumulation of the cells in the G 2 /M phase was (Fig. 3) .
The application of the two fluorinated taxanes at the deathinducing concentration (300 nM) also resulted in a significant accumulation of NCI/ADR-RES cells in the G 2 /M phase similarly to the application of SB-T-1216 and paclitaxel at the death-inducing concentration of 300 nM and 3,000 nM, respectively. Again, after 24 h of incubation with all taxanes examined, nearly total accumulation of the cells in the G 2 /M phase was observed as compared with the number of cells in G 1 phase. However, in the case of paclitaxel as 3,000 nM concentration, a significant accumulation of hypodiploid cells/particles was also detected (Fig. 4) . (Fig. 5) .
Concerning caspase-9 activity, nearly zero or zero activity was detected in control for both cell lines. However, a certain increase in caspase-9 activity was observed after the incubation with the taxanes at the Fig. 4 Effect of paclitaxel, SB-T-1216, SB-T-12853 and SB-T-12854 at death-inducing concentrations on the DNA histogram of resistant NCI/ ADR-RES cells. Control cells were incubated without taxane. After the incubation period (12, 24 h ), the cells were stained with propidium iodide (see "Materials and Methods") and analyzed by flow cytometry death-inducing concentrations. When comparing absolute values, the activity was 3.5 to 11-fold higher in NCI/ ADR-RES cells then in sensitive MDA-MB-435 cells (Fig. 5) .
The activity of caspase-2 increased approximately 2 to 3-fold in MDA-MB-435 cells after the incubation with all taxanes examined. In NCI/ADR-RES cells, the increase in caspase-2 activity was much more pronounced, i.e. 14 to 20-fold (Fig. 5) .
We observed only slight increase in caspase-8 activity for both MDA-MB-435 cells and NCI/ADR-RES cells after the incubation with the taxanes. The increase was 30-70% for MDA-MB-435 cells and 40-60% for NCI/ADR-RES cells (Fig. 5) .
Effect of taxanes on cytochrome c release
Flow cytometric analysis showed that after 24 h of incubation with SB-T-12853 and SB-T-12854 as well as taxane SB-T-1216 and paclitaxel at the death-inducing concentration, cytochrome c was not significantly released from the mitochondria in MDA-MB-435 cells. Similar data were obtained with the taxanes in NCI/ADR-RES cells (Fig. 6) .
These results were confirmed by Western blot analysis after cell fractionation. In both MDA-MB-435 cells and NCI/ADR-RES cells after the incubation with tested taxanes, cytochrome c was detected in the mitochondrial fraction, but not in the cytosolic fraction. As a control of proper fractionation, we performed Western blot analysis of the integral mitochondrial protein cytochrome c oxidase IV (COX IV) for both mitochondrial and cytosolic fractions. COX IV was only detected in the mitochondrial fraction of both cell lines (data not shown).
Effect of taxanes on mitochondrial functions
Employing flow cytometric analysis after staining cells with DiOC 6 (3), we assessed the effect of taxanes at the death-inducing concentrations on the mitochondrial membrane potential (Δψ m ) in both MDA-MB-435 cells and NCI/ADR-RES cells. With regard to the effect of 24-h incubation with SB-T-12853 and SB-T-12854 as well as SB-T-1216 and paclitaxel in both MDA-MB-435 cells and NCI/ADR-RES cells, we only detected a minor population of cells with decreased Δψ m when compared with the control cells (Fig. 7) .
Employing flow cytometric analysis using dihydroethidine probe, we also examined the effect of the taxanes on reactive oxygen species (ROS) production. We did not detect any significant increase of ROS level in both MDA-MB-435 and NCI/ADR-RES cells (Fig. 8) .
Discussion
The aim of the present study was to compare the cell deathinducing effect of new fluorinated taxanes SB-T-12851, SB-T-12852, SB-T-12853, SB-T-12854 on human cancer cells with that of classical taxane paclitaxel and novel nonfluorinated taxane SB-T-1216. We employed two human cancer cell lines MDA-MB-435 and NCI/ADR-RES. Cancer cell line MDA-MB-435 has been found in our previous study to be sensitive to paclitaxel in comparison with NCI/ADR-RES cell line, which has been shown to be highly resistant to paclitaxel [13] . Both cell lines were originally classified as cancer cell lines of breast cancer origin. However, recently their origin has been widely questioned [36, 37] . Thus the origin of these cell lines remains unclear. Nevertheless, they are still excellent models to study the effects of taxanes due to their differing drug sensitivity.
We showed previously that novel non-fluorinated taxane SB-T-1216 was significantly more effective than classical taxanes paclitaxel and docetaxel, particularly against drug- resistant cells [30, 31] . Thus, SB-T-1216 may represent a potentially powerful agent for the treatment of drugresistant cancers. In the current experiments we compared previously studied taxanes, paclitaxel and SB-T-1216, with the new fluorinated taxanes. Paclitaxel and SB-T-1216 were used as standards. Such design of the study allowed us to compare different taxanes under the same experimental conditions and also to assess the effects of fluorine incorporation into taxane molecule (e.g., SB-T-12854 vs. SB-T-1216, see Fig. 1 ) on cell growth and survival, cell cycle progression, activation of caspases and mitochondrial functions.
All fluorinated taxanes examined (SB-T-12851, SB-T-12852, SB-T-12853 and SB-T-12854), have similar effects on cell growth and survival of the cancer cell lines employed. Generally, the effects of tested fluorinated taxanes resemble that of previously studied non-fluorinated taxane SB-T-1216. Thus, our data confirmed that novel taxanes are more effective as to the inhibition of cancer cell growth and survival than paclitaxel, particularly against drugresistant cells.
We detected significant activation of the key executioner caspase-3 and also the activation of initiator caspase-9, representing the mitochondrial pathway of apoptosis induction, in both drug-sensitive MDA-MB-435 and drugresistant NCI/ADR-RES cells when cell death was induced by all tested taxanes. Such result may suggest the involvement of the mitochondrial pathway in the induction of apoptosis by taxanes. Therefore, we also investigated other mitochondrial functions.
It has been described that the intrinsic mitochondrial pathway is involved in apoptosis induction by taxanes [13, Fig. 8 Effect of paclitaxel, SB-T-1216, SB-T-12853 and SB-T-12854 at death-inducing concentrations on reactive oxygen species (ROS) production in sensitive MDA-MB-435 and resistant NCI/ADR-RES cells. Control cells were incubated without taxane. After 24 h of incubation, the ROS production was assessed by flow cytometric analysis of cells after staining with 5 μM dihydroethidium (see "Materials and Methods"). The analysis of cells without staining is shown (blank areas) 15, 16, [19] [20] [21] [22] , although other apoptotic pathways were reported as well [17, 18, 23] . In this study, we found that cytochrome c was not released from mitochondria during apoptosis induction by taxanes. However, in our previous study [13] we detected cytochrome c release when apoptosis was induced by paclitaxel at a very high concentration (3,000 nM) in drug-resistant cells. The difference could be ascribed to the use of different paclitaxel preparation containing an active component or contaminant. But we must wait for further investigation.
We also did not detect any significant change in the mitochondrial membrane potential (Δψ m ). Collapse of Δψ m is anticipated when the mitochondrial pathway is involved. Increased ROS production was not detected as well in this study. Generation of ROS was described previously as a result of paclitaxel treatment [38] . However, it seems that ROS does not play a significant role in apoptosis induced by taxanes for both cancer cell lines tested.
Thus it seems that the mitochondrial pathway is not the predominant pathway of apoptosis induction by taxanes in MDA-MB-435 and NCI/ADR-RES cells. The activation of caspase-9 may just represent a side effect.
Significant activation of caspase-2 and a certain activation of caspase-8 were also found in both cell lines. Caspase-2 has a unique position among caspases. It is suggested that caspase-2 is the most apical caspase in the apoptotic cascade when apoptosis is induced by DNA damage and cytotoxic stress [39, 40] . Several studies demonstrated caspase-2 activation in various types of cancer cells after apoptosis induction by taxanes [17, 41] . Thus caspase-2 may be a major player in apoptosis induction. Concerning caspase-8 activation, it suggests that the death receptor pathway of caspase activation could also be somehow involved in cell death induced by taxanes. The activation of caspase-8 was detected during taxane-induced apoptosis in lymphoma and melanoma cells [17, 41] .
Considering the activation of all caspases examined in this study, the functional sequence of the activation of individual caspases remains to be elucidated. We hypothesize that the key event of the induction of apoptosis by taxanes in the two cancer cell lines used for our study is the activation of caspase-2. Caspase-2 may act as the most apical caspase that is responsible for the activation of all other caspases including caspase-9.
Based on the results obtained in this study, new fluorinated taxanes appear to use the same or very similar mechanisms of cell death induction to exert their anticancer effects in vitro as compared with non-fluorinated taxane SB-T-1216 and the classical taxane paclitaxel. Fluorinated taxanes and non-fluorinated taxane SB-T-1216 examined in our experiments are significantly more effective against drug-resistant cancer cells than paclitaxel. Therefore, new generation taxanes, either non-fluorinated or fluorinated, are excellent candidates for further and detailed studies. These taxanes may provide a good treatment option for cancer patients refractory to the treatment with classical taxanes in the future.
